AVITA Medical, Inc. is a therapeutic acute wound care company. The Company’s technologies optimize wound healing, effectively accelerating the time to patient recovery. At the forefront of its platform is the RECELL System for the treatment of thermal burn wounds and full-thickness skin defects. RECELL harnesses the healing properties of a patient’s own skin to create Spray-On Skin Cells, offering a solution for improved clinical outcomes at the point-of-care. In the United States, it also holds the exclusive rights to market, sell, and distribute Cohealyx, an AVITA Medical-branded collagen-based dermal matrix, and PermeaDerm, a biosynthetic wound matrix. Its technologies are designed to optimize skin restoration procedures, effectively accelerating patient healing and recovery. Its solutions improve the healing outcomes for patients with traumatic injuries and surgical repairs, addressing critical healing needs that arise from unpredictable and life-changing events.
企業コードRCEL
会社名AVITA Medical Inc
上場日Mar 18, 2012
最高経営責任者「CEO」Vance (Cary G)
従業員数260
証券種類Ordinary Share
決算期末Mar 18
本社所在地28159 Avenue Stanford
都市VALENCIA
証券取引所NASDAQ OMX - NASDAQ BASIC
国United States of America
郵便番号91355
電話番号16613679170
ウェブサイトhttps://www.avitamedical.com/
企業コードRCEL
上場日Mar 18, 2012
最高経営責任者「CEO」Vance (Cary G)
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし